News

COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar’s COLOREX™ Media

June 14, 2019

COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar’s COLOREX™ Media

Read More

COPAN Announces FecalSwab® Stool Collection and Transport Device Certified Free of Nucleic Acids

March 28, 2019

COPAN Announces FecalSwab® Stool Collection and Transport Device Certified Free of Nucleic Acids

Read More

COPAN Maintains its Global Commitment to Address Unauthorized Use of its Patented Technology

January 16, 2019

COPAN is focused on the industry standard quality of its innovative products and remains actively committed to protecting its intellectual property rights globally, including the patent infringement and unfair competition lawsuit that COPAN filed in U.S. federal district court last year.

Read More

Summary Judgment in favor of COPAN against Puritan Medical Products’ Claim for Bad Faith Assertion of Patent Infringement

September 10, 2018

Maine’s highest court, the Maine Supreme Judicial Court, affirmed a summary judgment entered in favor of Copan Italia S.p.A. and against Puritan Medical Products Company, LLC on Puritan’s state law claim for bad faith assertion of patent infringement.

Read More

COPAN Announces the Worldwide Launch of CYCLONE AUTO-PREP™ with Smart Incubators and AI for Automatic Determination of Bacterial Growth During the Upcoming International Association for Food Protection (IAFP) Annual Meeting

July 3, 2018

COPAN Announces the Worldwide Launch of CYCLONE AUTO-PREP™ with Smart Incubators and AI for Automatic Determination of Bacterial Growth During the Upcoming International Association for Food Protection (IAFP) Annual Meeting

Read More

COPAN Announces Lawsuit for Patent Infringement and Unfair Competition Against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC

June 4, 2018

COPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779.

Read More

COPAN Defining the Future of Human Robot Collaboration in Clinical Microbiology Launching its Breakthrough Technology at ASM

June 1, 2018

COPAN announces its North American launch
of the new Collaborative Robot, its latest addition to Full Laboratory Automation.

Read More

Recent Multicenter JCM Publication Shows ESwab’s Versatility and Effectiveness in Detecting MRSA from Nasal Swabs on Cepheid’s Xpert MRSA Next Generation Assay

December 5, 2017

Recent multicenter study by Dr. Carey-Ann D. Burnham et al adds another application to the growing number of uses and endorsements for COPAN’s widely popular ESwab™. ESwab™ comprises of 1ml of liquid Amies and a flocked swab that completely elutes the sample into the preservation medium.

Read More

COPAN ITALIA and SHINJI MATSUURA Announce Joint Venture

November 9, 2017

Copan Italia and Shinji Matsuura proudly announce the formation of a joint venture for the strategic promotion and distribution of Copan’s Liquid Based Microbiology range in Japan.

Read More

New Automation at Sutter Health Shared Laboratory to Shorten Diagnosis Process, Length of Hospital Stays

October 20, 2017

Livermore, Calif. – October 20, 2017 – Not-for-profit Sutter Health and COPAN Diagnostics, Inc. (Murrieta, Calif.) today announced the deployment of full automation technology at the Sutter Health Shared Laboratory in Livermore. WASPLab® will improve patient care by speeding up the diagnosis process, leading to decreases in both cost and length of hospital stays.

Read More